Medtronic Diabetes Company Profile

00:26 EDT 20th March 2018 | BioPortfolio

At Medtronic Diabetes, our 20 plus year history vividly reflects our dedication and ongoing vision to develop an "artificial pancreas". In 1983, we pioneered the idea of continuous insulin delivery, introducing our first insulin pump in an effort to find a "better way" to deliver insulin for people with diabetes. Since that time, Medtronic Diabetes has remained the market leader, earning a reputation for excellence in insulin pump therapy and continuous glucose monitoring.


18000 Devonshire Street
United States of America

News Articles [1337 Associated News Articles listed on BioPortfolio]

Diabetes division leads Q3 sales growth in Medtronic

Medtronic's diabetes division saw a 17% increase in sales during the fiscal third quarter ending Jan.  -More- 

Medtronic gets FDA approval for Guardian Connect CGM system for diabetes patients

Medtronic has secured approval from the US Food and Drug Administration (FDA) for its Guardian Connect continuous glucose monitoring (CGM) system for people with diabetes ages 14 to 75 years.

Medtronic makes further moves into Type 2 diabetes with FDA approval of new CGM sensor

With the FDA approval of a new continuous glucose

FDA approves Medtronic's Guardian Connect CGM

Medtronic's Guardian Connect continuous glucose monitoring system was approved by the FDA for diabetes patients ages 14 to 75 -More- 

FDA Approves New 'Smart' Continuous Glucose Monitor for Diabetes

Designed for patients with diabetes who use multiple daily insulin injections, Medtronic's Guardian Connect is the first stand-alone CGM with predictive capability. Medscape Medical News

Medtronic (NYSE: $MDT) Receives FDA Approval for Guardian Connect Continuous Glucose Monitoring (CGM) System for People Living with Diabetes

DUBLIN - March 12, 2018 ( Newswire) Medtronic plc (NYSE:MDT), the global leader in medical technology, services and solutions, today announced it received U.S. Food and Drug Administr...

FDA Approves Medtronic Smart Continuous Glucose Monitoring (CGM) System for Diabetes

The FDA has just approved the Medtronic Guardian™ Connect Continuous Glucose Monitoring (CGM) system, the first smart CGM system to help people with diabetes outsmart high and low glucose events. Th...

Top 5 diabetes news reports from February

Endocrine Today has compiled a list of the top five diabetes news reports posted in readers were interested in a new indication for a glucose sensor, the safety and e...

Drugs and Medications [43 Associated Drugs and Medications listed on BioPortfolio]

Prialt® (ziconotide intrathecal infusion) [Elan Pharmaceuticals, Inc.]

PRIALT® (ziconotide intrathecal infusion)

Scot-tussin diabetes cough formula with dm [SCOT-TUSSIN Pharmacal Co., Inc.]

Scot-Tussin Diabetes Cough Formula with DM

Aspirin [Time-Cap Labs, Inc]


Novolin [Novo Nordisk]

Novolin 70/30, 70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin Injection (recombinant DNA origin)

Metformin hydrochloride [Solco Healthcare US LLC]

Rx only Metformin hydrochloride tablets(Metformin hydrochloride tablets, USP)

PubMed Articles [2195 Associated PubMed Articles listed on BioPortfolio]

Unilateral renal agenesis and abrupt onset diabetes: an unfrequent form of MODY type diabetes.

MODY diabetes encompasses heterogeneous group of monogenic forms of diabetes with low prevalence. It is not easily diagnosed because of the increase in obesity and family history of diabetes in the ge...

Role of the Diabetes Educator in Inpatient Diabetes Management.

It is the position of American Association of Diabetes Educators (AADE) that all inpatient interdisciplinary teams include a diabetes educator to lead or support improvement efforts that affect patien...

Diabetes and CKD in the United States Population, 2009-2014.

Diabetes is an important cause of CKD. However, among people with diabetes, it is unclear to what extent CKD is attributable to diabetes itself versus comorbid conditions, such as advanced age and hyp...

Randomized trial of the Carpentier-Edwards supra-annular prosthesis versus the Medtronic Mosaic aortic prosthesis: 10-year results.

We performed a prospective randomized study comparing the clinical performance of the Carpentier-Edwards supra-annular valve (CE-SAV) (Edwards Lifesciences, Irvine, CA, USA) and the newer Mosaic (Medt...

Who's distressed? A comparison of diabetes-related distress by type of diabetes and medication.

We hypothesized that diabetes-related distress would vary by type of diabetes and medication regimen [Type 1 diabetes (T1DM), Type 2 diabetes with insulin use (T2DM-i), Type 2 diabetes without insulin...

Clinical Trials [4664 Associated Clinical Trials listed on BioPortfolio]

Glycemic Control and the Brain in Children With Type 1 Diabetes

The purpose of this study is to determine if improving diabetes control by better controlling blood sugars, will help improve or normalize brain function as compared to routine diabetes ca...

Hypoglycaemia and Cardiac Arrhythmias in Type 2 Diabetes

Twenty-one patients with insulin-treated type 2 diabetes with diabetic complications will be recruited to Part 1 of the study, a three-hour combined hyper- and hypoglycaemic clamp, along w...

Utility of the Audible Alert in Current Generation Medtronic Implantable Cardioverter-defibrillators

The purpose of this study is to determine whether the alert tones emitted by the latest generation of Medtronic implantable cardioverter-defibrillators (ICDs) are audible to patients. ...

Spinal Cord Stimulation (SCS) Therapy Study

The purpose of this study is to evaluate the effect of different spinal cord stimulation settings in the treatment of leg pain. Subjects will receive a randomized order of four different p...

A Crossover Study Comparing Two Automated Insulin Delivery System Algorithms in Adolescents and Young Adults With Type 1 Diabetes

Adolescents and young adults with type 1 diabetes often have a difficult time achieving good glucose control which is so important in reducing the risk for diabetes complications. Despite ...

Companies [504 Associated Companies listed on BioPortfolio]

Medtronic Diabetes

At Medtronic Diabetes, our 20 plus year history vividly reflects our dedication and ongoing vision to develop an "artificial pancreas". In 1983, we pioneered the idea of continuous insulin delivery, i...

Medtronic, Inc.

Medtronic, Inc. (, headquartered in Minneapolis, is the global leader in medical technology – alleviating pain, restoring health, and extending life for mil...

Medtronic plc

Medtronic plc (, headquartered in Dublin, Ireland, is the global leader in medical technology – alleviating pain, restoring health and extending life for ...

Medtronic Foundation & Project HOPE

Medtronic, Inc. (, headquartered in Minneapolis, is the global leader in medical technology – alleviating pain, restoring health, and extending life for million...

Functional Neuromodulation, Ltd

Founded in Toronto, Ontario in 2010, Functional Neuromodulation is dedicated to advancing the application of deep brain stimulation (DBS) therapies to help improve the lives of pe...

More Information about "Medtronic Diabetes" on BioPortfolio

We have published hundreds of Medtronic Diabetes news stories on BioPortfolio along with dozens of Medtronic Diabetes Clinical Trials and PubMed Articles about Medtronic Diabetes for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Medtronic Diabetes Companies in our database. You can also find out about relevant Medtronic Diabetes Drugs and Medications on this site too.

Quick Search


Relevant Topic

Nephrology - kidney function
Nephrology is a specialty of medicine and pediatrics that concerns itself with the study of normal kidney function, kidney problems, the treatment of kidney problems and renal replacement therapy (dialysis and kidney transplantation). Systemic conditions...

Corporate Database Quicklinks

Searches Linking to this Company Record